1. CD8+ T cells from a novel T cell receptor transgenic mouse induce liver-stage immunity that can be boosted by blood-stage infection in rodent malaria
- Author
-
Diana S. Hansen, Lei Shong Lau, William R. Heath, Julia L. Gregory, Francis R. Carbone, Scott R. Burrows, Tania F. de Koning-Ward, Kenneth M. Murphy, Christian R. Engwerda, Gayle M. Davey, Catherine Q Nie, Ashraful Haque, Yi-Hsuan Lin, Anthony T. Papenfuss, Anton Cozijnsen, Vanessa Mollard, Claerwen M. Jones, Michelle A Neller, Angelika Sturm, John J. Miles, Geoffrey I. McFadden, Daniel Fernandez-Ruiz, and Brendan S. Crabb
- Subjects
Male ,Plasmodium berghei ,Priming (immunology) ,CD8-Positive T-Lymphocytes ,Interleukin 21 ,Mice ,Cytotoxic T cell ,Biology (General) ,Immune Response ,Cells, Cultured ,Adoptive Transfer ,3. Good health ,medicine.anatomical_structure ,Blood ,Liver ,Plasmodium chabaudi ,Sporozoites ,Research Article ,QH301-705.5 ,T cell ,Immunology ,Immunization, Secondary ,Receptors, Antigen, T-Cell ,Mice, Transgenic ,Immunopathology ,Biology ,Major histocompatibility complex ,Microbiology ,Antigen ,Virology ,Anopheles ,parasitic diseases ,Genetics ,medicine ,Animals ,Molecular Biology ,Immunity to Infections ,Life Cycle Stages ,Immunity ,Biology and Life Sciences ,Plasmodium yoelii ,RC581-607 ,biology.organism_classification ,R1 ,Acquired Immune System ,Malaria ,Mice, Inbred C57BL ,Immune System ,biology.protein ,Parasitology ,Clinical Immunology ,Immunologic diseases. Allergy ,CD8 - Abstract
To follow the fate of CD8+ T cells responsive to Plasmodium berghei ANKA (PbA) infection, we generated an MHC I-restricted TCR transgenic mouse line against this pathogen. T cells from this line, termed PbT-I T cells, were able to respond to blood-stage infection by PbA and two other rodent malaria species, P. yoelii XNL and P. chabaudi AS. These PbT-I T cells were also able to respond to sporozoites and to protect mice from liver-stage infection. Examination of the requirements for priming after intravenous administration of irradiated sporozoites, an effective vaccination approach, showed that the spleen rather than the liver was the main site of priming and that responses depended on CD8α+ dendritic cells. Importantly, sequential exposure to irradiated sporozoites followed two days later by blood-stage infection led to augmented PbT-I T cell expansion. These findings indicate that PbT-I T cells are a highly versatile tool for studying multiple stages and species of rodent malaria and suggest that cross-stage reactive CD8+ T cells may be utilized in liver-stage vaccine design to enable boosting by blood-stage infections., Author Summary Malaria is a disease caused by Plasmodium species, which have a highly complex life cycle involving both liver and blood stages of mammalian infection. To prevent disease, one strategy has been to induce CD8+ T cells against liver-stage parasites, usually by immunization with stage-specific antigens. Here we describe a T cell receptor specificity that recognizes an antigen expressed in both the liver and blood stages of several rodent Plasmodium species. We generated a T cell receptor transgenic mouse with this specificity and showed that T cells from this line could protect against liver-stage infection. We used this novel tool to identify the site and cell-type involved in priming to a recently developed intravenous attenuated sporozoite vaccine shown to have efficacy in humans. We showed that CD8+ T cells with this specificity could protect against liver-stage infection while causing pathology to the blood stage. Finally, we provided evidence that T cells with cross-stage specificity can be primed and boosted on alternative stages, raising the possibility that antigens expressed in multiple stages might be ideal vaccine candidates for generating strong immunity to liver-stage parasites.
- Published
- 2014